Article Details

Bicycle Therapeutics (NASDAQ:BCYC) Upgraded to “Hold” at Zacks Investment Research

Retrieved on: 2019-12-17 20:56:15

Tags for this article:

Click the tags to see associated articles and topics

Bicycle Therapeutics (NASDAQ:BCYC) Upgraded to “Hold” at Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Atlas Venture</b> Advisors Inc. acquired a new position in Bicycle Therapeutics in the second quarter valued at $13,709,000. Victory Capital Management ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up